3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
4
Breast Neoplasms
4
Triple Negative Breast Neoplasms
2
Myeloproliferative Disorders
2
Melanoma
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
von Hippel-Lindau Disease
1
Thrombosis
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Skin Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Pyruvate Kinase Deficiency of Red Cells
1
Neuroendocrine Tumors
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Myelitis, Transverse
1
Myasthenia Gravis
1
Multiple Sclerosis
1
Metastatic Castration-resistant Prostate Cancer
1
Marijuana Abuse
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Lymphedema
1
Locally Advanced Head and Neck Carcinoma
1
Liver Neoplasms
1
Interventions
durvalumab
2
Tretinoin
2
Paclitaxel
2
Carboplatin
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
talazoparib
1
sarilumab
1
pexidartinib
1
pertuzumab
1
pembrolizumab
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
dostarlimab
1
cemiplimab
1
abemaciclib
1
Trastuzumab
1
Standard of Care
1
STA 9090
1
SGN-LIV1A
1
Pemetrexed
1
MK 2206
1
Letrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Blood Specimen Collection
×
30 days
×
Clear all
No trials found.